Apoptosis of pancreatic B-cells detected in accelerated diabetes of NOD mice: No role of Fas-Fas ligand interaction in autoimmune diabetes

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 455-465

  Kim, Yun Hee ^a   Kim, Sunshin ^a   Kim, Kyung Ah ^a   Yagita, Hideo ^b   Kayagaki, Nobuhiko ^b   Kim, Kwang Won ^a   Lee, Myung Shik ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Diabetes; Fas; Lpr

Indexed keywords

CONCANAVALIN A; CYCLOPHOSPHAMIDE; FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; MEMBRANE PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PATHOLOGY;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; ISLETS OF LANGERHANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD;

EID: 0032586826     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<455::AID-IMMU455>3.0.CO;2-A     Document Type: Article

References (36)

1. Wicker, L. A., Miller, B. J. and Mullen, Y., Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986. 35: 855-860.
2. Wang, Y., Pontesilli, O., Gill, R. D., La Rosa, F. G. and Lafferty, K. J., The role of CD4+ and CDS+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 1991. 88: 527-531.
3. Haskins, K. and McDuffie, M., Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990. 249: 1433-1436.
4. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. and Golstein, P., Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994. 265: 528-530.
5. Ju, S.-T., Cui, H., Panka, D. J., Ettinger, R. and Marshak-Rothstein, A., Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 1994. 91: 4185-4189.
6. Henkart, P. A., Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994. 1: 343-346.
7. Kagi, D., Odermatt, B., Ohashi, P. S., Zinkernagel, R. M. and Hengartner, H., Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity. J. Exp. Med. 1996. 183: 2143-2152.
8. Kagi, D., Odermatt, B., Seiler, P., Zinkernagel, R. M., Mak, T. W. and Hengartner, H., Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 1997. 186: 989-997.
9. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A. and Matis, L. A., The role of Fas in autoimmune diabetes. Cell 1997. 89: 17-24.
10. Itoh, N., Imagawa, A., Hanafusa, T., Waguri, M., Yamamoto, K., Iwasashi, H., Moriwaki, M., Nakajima, H., Miyagawa, M., Manba, M., Makino, S., Nagata, S., Kono, N. and Matsuzawa, Y., Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 1997. 186: 613-618.
11. Yamada, K., Takane-Gyotoku, N., Yuan, X., Ichikawa, F. and Nonaka, K., Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 1996. 39: 1306-1312.
12. Kurrer, M. O., Pakala, S. V., Hanson, H. L. and Katz, J. D., β cell apoptosis in T cell-mediated autoimmune diabetes. Proc. Natl. Acad. Sci. USA 1997. 94: 213-218.
13. Blunt, T., Finnic, N. J., Taccioli, G. E., Smith, G. C., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A. and Jackson, S. P., Defective DMA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine seid mutation. Cell 1995. 80: 813-823.
14. Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S., Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 1995. 14: 12-18.
15. Chu, J. L., Ramos, P., Rosendorff, A., Nikolic-Zugic, J., Lacy, E., Matsuzawa, A. and Elkon, K. B., Massive upregulation of the Fas ligand in lpr and gld mice: Implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J. Exp. Med. 1995. 181: 393-398.
16. Reap, E. A., Roof, K., Maynor, K., Borrero, M., Booker, J. and Cohen, P. L, Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interaction. Proc. Natl. Acad. Sci. USA 1997. 94: 5750-5755.
17. Harada, M. and Makino, S., Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 1984. 27: 604-606.
18. Mitsuoka, A., Baba, M. and Morikawa, S., Enhancement of delayed hypersensitivity by depletion or suppressor T cells with cyclophosphamide. Nature 1976. 262: 77-78.
19. Yasunami, R. and Bach, J.-F., Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 1988. 18: 481-484.
20. O'Brien, B. A., Harmon, B. V., Cameron, D. P. and Allan, D. J., Apoptosis is the mode of b-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 1997. 46: 752-757.
21. Havrilesky, L. J., Elbendary, A., Hurteau, J. A., Whitaker, R. S., Rodriguez, G. C. and Berchuck, A., Chemotherapy-induced apoptosis in epithelial ovarian cancers. Obstet. Gynecol. 1995. 85: 1007-1010.
22. Rothe, H., Schade, U., Kleemann, R., Bosse, G., Hibino, T., Martin, S. and Kolb, H., Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994. 37: 1154-1158.
23. Hiramine, C., Nakagawa, T., Miyauchi, A. and Hojo, K., Thymic nurse cells as the site of thymocyte apoptosis and apoptotic cell clearance in the thymus of cyclophosphamide-treated mice. Lab. Invest. 1996. 75: 185-201.
24. Colucci, R, Cilio, C. M., Lejon, K., Goncalves, C. P., Bergman, M.-L. and Holmberg, D., Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J. Autoimmun. 1996. 9: 271-276.
25. Ramsdell, F., Seaman, M. S., Miller, R. E., Picha, K. S., Kennedy, M. K. and Lynch, D. H., Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 1994. 6: 1545-1553.
26. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F. and Lynch, D. H., Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995. 181: 71-77.
27. Leeson, T. S., Leeson, C. R. and Paparo, A. A. (Eds.) Text/atlas of histology. W. B. Saunders Company, Philadelphia 1988, p 471.
28. Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H. and Okumura, K., Differential effects of anti-Fas ligand and anti-TNFa antibodies on acute graft-versus-host disease pathologies. Stood 1998. 91: 4051-4055.
29. Lee, M.-S., Kim, S., Chung, C. H., Lee, M.-K. and Kim, K.-W., Fas is expressed in murine pancreatic islet cells and an insulinoma cell line but does not mediate their in vitro apoptosis. Autoimmunity, in press.
30. Picarella, D. E., Kratz, A., Li, C., Ruddle, N. H. and Flavell, R. A., Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insultitis, not diabetes. J. Immunol. 1993. 150: 4136-4150.
31. Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway, C. A. and Flavell, R. A., Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells. J. Exp. Med. 1996. 184: 1963-1974.
32. Surh, C. D. and Sprent, J., T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994. 372: 100-103.
33. Kayagaki, N., Yamaguchi, N., Nagao, F., Matsuo, S., Maeda, H., Okumura, K. and Yagita, H., Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 1997. 94: 3914-3919.
34. Seino, K.-I., Kayagaki, N., Takeda, K., Fukao, K., Okumura, K. and Yagita, H., Contribution of Fas ligand to T-cell-mediated hepatic injury in mice. Gastroenterology 1997. 113: 1315-1322.
35. Adachi, M., Watanabe-Fukunaga, R. and Nagata, S., Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 1993. 90: 1756-1760.
36. Hyldig-Nielsen, J. J., Schenning, L., Hämmerling, U., Widmark, E., Heldin, E., Lind, P., Servenius, B., Lung, T., Flavell, R., Lee, J. S., Trowsdale, J., Schreier, P. H., Zablitzky, F., Larhammar, D., Peterson, P. A. and Rask, L., The complete nucleotide sequence of the I-Ead response gene. Nucleic Acids Res. 1983. 11; 5055-5071.